Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

562 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis.
Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L. Paul C, et al. Among authors: chevret s. Br J Dermatol. 2002 Sep;147(3):518-22. doi: 10.1046/j.1365-2133.2002.04833.x. Br J Dermatol. 2002. PMID: 12207594 Clinical Trial.
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group. Gouilleux-Gruart V, et al. Among authors: chevret s. Clin Exp Immunol. 2013 Feb;171(2):186-94. doi: 10.1111/cei.12002. Clin Exp Immunol. 2013. PMID: 23286945 Free PMC article.
Treatment of common variable immunodeficiency disorders (CVID) is based on replacement therapy using intravenous (i.v.) or subcutaneous (s.c.) immunoglobulin (Ig)G. ...
Treatment of common variable immunodeficiency disorders (CVID) is based on replacement therapy using intravenous (i.v.) or subcutaneous ( …
Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome.
Bige N, Zafrani L, Lambert J, Peraldi MN, Snanoudj R, Reuter D, Legendre C, Chevret S, Lemiale V, Schlemmer B, Azoulay E, Canet E. Bige N, et al. Among authors: chevret s. Transpl Infect Dis. 2014 Aug;16(4):588-96. doi: 10.1111/tid.12249. Epub 2014 Jun 26. Transpl Infect Dis. 2014. PMID: 24966154
Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 days.
Raphael JC, Chevret S, Harboun M, Jars-Guincestre MC; French Guillain-Barré Syndrome Cooperative Group. Raphael JC, et al. Among authors: chevret s. J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):235-8. doi: 10.1136/jnnp.71.2.235. J Neurol Neurosurg Psychiatry. 2001. PMID: 11459901 Free PMC article. Clinical Trial.
Plasma exchange for Guillain-Barré syndrome.
Raphaël JC, Chevret S, Hughes RA, Annane D. Raphaël JC, et al. Among authors: chevret s. Cochrane Database Syst Rev. 2002;(2):CD001798. doi: 10.1002/14651858.CD001798. Cochrane Database Syst Rev. 2002. PMID: 12076424 Updated. Review.
It involves connecting the patient's blood circulation to a machine which exchanges the plasma for a substitute solution, usually albumin. ...REVIEWER'S CONCLUSIONS: Plasma exchange is the first and only treatment that has been proven to be superior to supportive tr …
It involves connecting the patient's blood circulation to a machine which exchanges the plasma for a substitute solution, usually alb …
Plasma exchange for Guillain-Barré syndrome.
Raphaël JC, Chevret S, Hughes RA, Annane D. Raphaël JC, et al. Among authors: chevret s. Cochrane Database Syst Rev. 2001;(2):CD001798. doi: 10.1002/14651858.CD001798. Cochrane Database Syst Rev. 2001. PMID: 11406009 Updated. Review.
It involves connecting the patient's blood circulation to a machine which exchanges the plasma for a substitute solution, usually albumin. ...REVIEWER'S CONCLUSIONS: Plasma exchange is the first and only treatment that has been proven to be superior to supportive tr …
It involves connecting the patient's blood circulation to a machine which exchanges the plasma for a substitute solution, usually alb …
Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.
Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Gajdos P, et al. Among authors: chevret s. Ann N Y Acad Sci. 1998 May 13;841:720-6. doi: 10.1111/j.1749-6632.1998.tb11008.x. Ann N Y Acad Sci. 1998. PMID: 9668320 Clinical Trial. No abstract available.
Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Gajdos P, et al. Among authors: chevret s. Ann Neurol. 1997 Jun;41(6):789-96. doi: 10.1002/ana.410410615. Ann Neurol. 1997. PMID: 9189040 Clinical Trial.
Intravenous immunoglobulin for myasthenia gravis.
Gajdos P, Chevret S, Toyka K. Gajdos P, et al. Among authors: chevret s. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002277. doi: 10.1002/14651858.CD002277.pub3. Cochrane Database Syst Rev. 2008. PMID: 18254004 Updated. Review.
Intravenous immunoglobulin for myasthenia gravis.
Gajdos P, Chevret S, Toyka K. Gajdos P, et al. Among authors: chevret s. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002277. doi: 10.1002/14651858.CD002277.pub2. Cochrane Database Syst Rev. 2006. PMID: 16625559 Updated. Review.
562 results
Jump to page
Feedback